Weekly: Halozyme Therapeutics (HALO: $33.38) accelerates decline: down 8.7% in 2 weeks; -$1.78 [5.1%]

Press/Media

PeriodOct 28 2023

Media coverage

1

Media coverage

  • TitleWeekly: Halozyme Therapeutics (HALO: $33.38) accelerates decline: down 8.7% in 2 weeks; -$1.78 [5.1%]
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date10/28/23
    PersonsMary Daly
View all 1
View less